GLP-1 Medications in Italy 2026: Ozempic, Wegovy, and Access

GLP-1 in Italy: SSN coverage criteria, private pharmacy prices for Ozempic and Mounjaro, prescription rules. Updated May 2026.

Regimen Team · · 7 min read

If you’re in Italy and exploring GLP-1 medications, you’re in a market where access has improved significantly in the past two years. Ozempic is well-established, Wegovy is approved, Mounjaro is here. The picture on what’s covered, what you’ll pay privately, and how to get started looks like this.

What’s Approved and Available in Italy

AIFA (Agenzia Italiana del Farmaco) is Italy’s equivalent of the FDA. All major GLP-1 medications are approved through EMA/AIFA and available in Italian pharmacies.

MedicationApproved forSSN pays?
Ozempic (semaglutide)Type 2 diabetesType 2 diabetes only (Nota 100)
Wegovy (semaglutide)Weight managementNo, classe C
Mounjaro (tirzepatide)Type 2 diabetes and weight managementType 2 diabetes only (Nota 100)
Saxenda (liraglutide)Weight managementNo, classe C

Mounjaro €346.58-623.86 a pen (AIFA class A list 31/05/2026, diabetes pack); Ozempic €168.82 a pen on the same list; Wegovy is classe C with no AIFA price: Mounjaro prezzo, the Italian price guide.

On Ozempic? Regimen’s Ozempic app logs the shot in one tap, reminds you before the next one, and ties your side effects and weight to each dose step.

SSN Coverage: What Actually Qualifies

For type 2 diabetes

Ozempic is covered by the SSN for T2DM patients meeting prescribing criteria. This is a well-established pathway. If you’re managing type 2 diabetes, your endocrinologist or diabetologist can prescribe Ozempic on a reimbursed basis.

Mounjaro is available in Italy and reimbursed for adults with T2DM under the same AIFA Nota 100.

For weight management only

The SSN does not pay, in any region. AIFA’s Comunicato n. 21 of 18 May 2026 says Wegovy, Saxenda and Mounjaro prescribed for weight management are not reimbursed by the SSN: they are classe C, paid by the patient. Law 149 of 3 October 2025 recognises obesity as a disease but does not fund the medicines.

Pro Tip

If you have type 2 diabetes, ask your diabetologist whether Ozempic or Mounjaro can be prescribed under Nota 100. That is the only reimbursed route for these medicines in Italy.

Private Access: The Realistic Path for Most

For weight management, a private prescription is the only route.

Any licensed Italian physician can prescribe GLP-1 medications privately. Endocrinologists and general physicians in major Italian cities (Milan, Rome, Bologna, Florence, Naples) regularly prescribe Wegovy and Ozempic privately for weight management.

Mounjaro’s AIFA list price for the reimbursed diabetes pack is €346.58 to €623.86 a pen (four weekly doses). For weight management AIFA publishes no price, for Mounjaro or for Wegovy, so ask the pharmacy before you buy. The Italian price guide has every strength.

Community Insight

The most common feedback from Italian GLP-1 users: getting a prescription privately is not difficult in major cities, but pharmacies in smaller towns may need to order stock. Milan and Rome pharmacies reliably have it in hand. Outside major urban centers, call ahead.

Italy’s GLP-1 Market Context

The Italian GLP-1 market has grown significantly since 2023. Southern Italy has some of the highest obesity rates in Europe. The demand is real and the prescriber awareness is following it.

One Italy-specific note: the Italian aesthetic medicine and anti-aging scene is sophisticated, particularly in northern Italy. Private clinics in Milan and Bologna that already handle TRT and anti-aging protocols have been integrating GLP-1 prescribing naturally. If you’re already working with a men’s health or anti-aging clinic in Italy, ask about GLP-1 directly. Many now offer it.

Warning

Avoid sourcing GLP-1 medications from unregulated online suppliers. Italian customs (Agenzia delle Dogane) has stricter enforcement on imported unregistered medicines than some other European countries. Stick to pharmacy-dispensed, AIFA-approved products with a valid Italian prescription.

Tracking Your GLP-1 Protocol

Weekly GLP-1 injections come with a titration schedule that takes 4 to 5 months to complete. Tracking each dose, your weight trend, and any side effects at each tier helps you build a clear picture of how you’re responding.

Use the GLP-1 Dose Calculator to map out your titration schedule and calculate per-dose volumes.

If you want to compare tracking apps before settling on one, start with the best GLP-1 tracker apps.

If you’re also on TRT, see the Italy TRT Guide for how the two protocols interact in the Italian system.

This article is for informational purposes only and does not constitute medical advice, and no price here is a purchase recommendation. AIFA classifications and prices change, so check current status at aifa.gov.it. Prices checked 19 October 2026. Discuss all treatment decisions with your healthcare provider.

Ready to track your GLP-1?

  • Smart reminders so you never miss a dose
  • Track weight, photos, and progress over time
  • Medication level curves for 150+ compounds

Frequently Asked Questions

Is Ozempic available in Italy in 2026?

Yes. Ozempic is approved for type 2 diabetes and dispensed in Italian pharmacies on prescription. The SSN covers it for type 2 diabetes under Nota 100; prescribed for weight loss, you pay for it yourself.

Is Wegovy available in Italy?

Yes, on prescription, from 0.25 to 2.4 mg. It is classe C: the SSN does not pay for it, and AIFA publishes no price, so ask the pharmacy for the current price.

How much does Ozempic cost privately in Italy?

€168.82 a pen for 0.25, 0.5 or 1 mg on AIFA’s class A list (31 May 2026), for the reimbursed diabetes use. Prescribed for weight loss it is not reimbursed, so ask the pharmacy what you will pay.

Can my GP prescribe GLP-1 medications in Italy?

Yes. Any licensed Italian physician can prescribe GLP-1 medications. For SSN reimbursement, specialist involvement (endocrinologist, diabetologist) is typically required. For private prescription, a GP can prescribe directly.

Does SSN coverage for GLP-1 medications vary by region in Italy?

Not for weight management. AIFA’s classe C classification is national, so Wegovy, Saxenda and Mounjaro for weight are self-paid in every region. Regions only organise how reimbursed diabetes medicines are dispensed.

Regimen peptide and GLP-1 tracker app screenshot

Get the app

Track your GLP-1 protocol in Regimen.

Reminders that keep you on track, and built-in pattern detection that shows how your body responds.

Free to download. Free for your first compound.

Regimen app Today view with doses and estimated levels